These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8270182)

  • 41. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnancy, delivery and lactation in hyperprolactinaemic women.
    Sas M; Godó G; Koloszár S
    Acta Med Hung; 1986; 43(1):13-22. PubMed ID: 3774415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
    Moro M; Maraschini C; Toja P; Masala A; Alagna S; Rovasio PP; Ginanni A; Lancranjan I; Cavagnini F
    Horm Res; 1991; 35(3-4):137-41. PubMed ID: 1806467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Idiopathic hyperprolactinemia in a 15-year-old boy: a case report and literature review.
    Jaruratanasirikul S; Janejindamai S
    J Med Assoc Thai; 1995 Jul; 78(7):388-92. PubMed ID: 7658185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
    Verhelst JA; Froud AL; Touzel R; Wass JA; Besser GM; Grossman AB
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):385-91. PubMed ID: 1683503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperprolactinaemia and reproductive failure.
    Gunaratne M
    Ceylon Med J; 1993 Dec; 38(4):181-3. PubMed ID: 8143334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma beta-endorphin concentrations during suckling in lactating women.
    Franceschini R; Venturini PL; Cataldi A; Barreca T; Ragni N; Rolandi E
    Br J Obstet Gynaecol; 1989 Jun; 96(6):711-3. PubMed ID: 2529899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term pergolide treatment of hyperprolactinemic patients previously unsuccessfully treated with dopaminergic drugs.
    Berezin M; Avidan D; Baron E
    Isr J Med Sci; 1991 Jul; 27(7):375-9. PubMed ID: 2071373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experiences with the treatment of clinical hyperprolactinaemia.
    Nagy P; Szilágyi A; Csaba IF
    Zentralbl Gynakol; 1987; 109(12):788-94. PubMed ID: 3630462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia.
    Kletzky OA; Borenstein R; Mileikowsky GN
    Am J Obstet Gynecol; 1986 Feb; 154(2):431-5. PubMed ID: 3080892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
    Kano T; Nishikawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical study on effect of Bushen Tiaogan Lianru recipe on hyperprolactinemia].
    Liu J; Wang J; Chen X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Mar; 18(3):142-4. PubMed ID: 11367660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma levels of beta-endorphin, prolactin and gonadotropins in male athletes after an international nordic ski race.
    Mougin C; Henriet MT; Baulay A; Haton D; Berthelay S; Gaillard RC
    Eur J Appl Physiol Occup Physiol; 1988; 57(4):425-9. PubMed ID: 2969335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of hyperprolactinemia with pergolide.
    Mattox JH; Bernstein J; Buckman MT
    Int J Fertil; 1986; 30(4):39-43. PubMed ID: 2890594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of acute alcohol intoxication on pituitary-gonadal axis hormones, pituitary-adrenal axis hormones, beta-endorphin and prolactin in human adults of both sexes.
    Frias J; Torres JM; Miranda MT; Ruiz E; Ortega E
    Alcohol Alcohol; 2002; 37(2):169-73. PubMed ID: 11912073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Our experience in using bromocriptine-Richter in gynecology (a preliminary report)].
    Marinov B; Tsankova M; Kolarov G
    Akush Ginekol (Sofiia); 2000; 39 Suppl 1():20-1. PubMed ID: 10948639
    [No Abstract]   [Full Text] [Related]  

  • 60. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
    Vermesh M; Fossum GT; Kletzky OA
    Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.